Symphony Financial, Ltd. Co. Bristol Myers Squibb CO Transaction History
Symphony Financial, Ltd. Co.
- $619 Million
- Q4 2024
A detailed history of Symphony Financial, Ltd. Co. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Symphony Financial, Ltd. Co. holds 21,843 shares of BMY stock, worth $1.29 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
21,843
Previous 17,802
22.7%
Holding current value
$1.29 Million
Previous $921,000
34.09%
% of portfolio
0.2%
Previous 0.15%
Shares
16 transactions
Others Institutions Holding BMY
# of Institutions
2,612Shares Held
1.46BCall Options Held
31.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$11.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.49 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.61 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.61 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $126B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...